CROMA-PHARMA®, a global leader in minimally-invasive aesthetic medicine, is excited to announce that its range of injectable polynucleotides “PhilArt” is rebranding to better reflect the products’ exceptional attributes and to position them for global market expansion.
PolyPhil™ succeeds the well-established PhilArt range, offering a unique, effective portfolio of injectable polynucleotides known for their safety, efficacy, and cutting-edge technology. This change will enhance the products’ recognition across international markets, reinforcing Croma’s commitment to providing pioneering and effective treatments.
With the on-going demand for our Polynucleotide portfolio, this name change will better encompass what the product does and will broaden reach in all markets, aiding to global brand awareness. The quality and efficacy of the product remain unchanged and Croma UK will dedicate investment and support for this rebrand.
Vikki Baker, Head of Marketing UK IRE NL
Key benefits of PolyPhil™:
◆ Safety and Tolerance: Biocompatible with a minimal risk of adverse effects1
◆ Biorevitalisation of the Skin: Enhances skin structure, elasticity, and density
◆ Collagen stimulation: Activates natural mechanisms for collagen synthesis and regeneration
◆ Versatile Applications: Effective for the face, neck, décolletage, hands, and delicate eye areas
◆ High Patient Satisfaction: 91% clinical improvement in reducing fine lines and improving skin quality2
Unlock innovation with PolyPhil™
PolyPhil™ has proven efficacy supported by extensive clinical data.1
It utilises the polynucleotides – high purification technology (PN-HPT™), derived from water sources in a controlled environment ensuring safety and quality through a unique technology in a European-based production facility.
More than just a skin booster – A versatile treatment tool
With the Skin Enhancement Technique (SET), PolyPhil™ complements other aesthetic treatments such as laser therapies, microneedling, and chemical peels. This combination enables natural restoration for optimal skin conditions.1
References:
1. Cavallini et al. Consensus report on the use of PN-HPT™ (polynucleotides highly purified technology) in aesthetic medicine J Cosmet Dermatol. 2020;00:1–7.
2. Cavallini and Papagni, Long chain polynucleotides gel and skin biorevitalization; Journal of Plastic Dermatology 2007; 3,
FURTHER INFORMATION
Croma-Pharma
info.uk@cromapharma.com
